Sulfasalazine Therapy

Introduction to Sulfasalazine

The American Gastroenterological Association recommends sulfasalazine for the treatment of mild to moderate ulcerative colitis, with a typical dosing range of 1.5 to 4.0 g daily 1
Patients often need to start at lower doses with gradual escalation as tolerated due to side effects 2

Sulfasalazine is effective for inducing and maintaining remission in ulcerative colitis, with comparable efficacy to other 5-ASA preparations, though with more side effects 3, 4, 2
The medication has limited efficacy in peripheral arthritis associated with inflammatory bowel disease, but can be effective in large-joint arthropathy 5, 6
Sulfasalazine is not effective for axial spondyloarthritis 6
Gastrointestinal effects, such as nausea, vomiting, diarrhea, abdominal pain, and dyspepsia, occur in up to 35% of patients 2
Hematologic toxicity, including leukopenia, thrombocytopenia, and anemia, can occur 2
Hepatotoxicity, including elevated liver enzymes and rare cases of hepatitis, can also occur 2

Complete blood count monitoring is recommended due to potential hematologic toxicity 2
Liver function tests should be monitored 2
Sulfasalazine interferes with folic acid metabolism, requiring folate supplementation 2
Patients with concomitant arthritic symptoms may benefit from its use in ulcerative colitis 2
In patients with inflammatory bowel disease-associated peripheral spondyloarthritis, sulfasalazine can be considered for mild disease 7

Mesalamine and diazo-bonded 5-ASA medications are generally better tolerated than sulfasalazine 4, 2
Mesalamine and balsalazide have similar efficacy to sulfasalazine but with fewer side effects 4, 2
Systemic exposure to 5-ASA is similar across all oral mesalamine preparations and diazo-bonded 5-ASAs 4